Welcome to industryreportstore.com

Browse the latest reports in the Company SWOTs industry below

3610 Item(s)

Page 1 of 361

  1. ACADIA Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review more info

    Acadia Pharmaceuticals Inc. (Acadia) is a biopharmaceutical company, engaged in discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company focuses on developing a portfolio of four advanced product candidates such as Pimavanserin, which is in phase III development for Parkinson’s disease psychosis. In, addition, the company is developing AGN XX/YY, a phase II for chronic pain and AC-262271 in phase I for glaucoma in collaboration with Allergan as well as IND-track development in collaboration with Meiji Seika Keisha. Acadia has established collaboration partnerships with companies like Biovail, Allergen Inc.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH66258FSA
    PAGES: 40 TABLES: 24 FIGURES & CHARTS: 6
    $125.00
  2. Henry Schein, Inc. (HSIC) - Financial and Strategic SWOT Analysis Review more info

    Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It serves more than 775,000 customers worldwide, including dental practitioners and laboratories, physician practices and veterinary clinics, government and other institutions. The company operates along with its subsidiaries in Germany, Canada, France, Switzerland, the UK and the US. It also manages affiliates in Iceland, Saudi Arabia and Turkey. Henry Schein is headquartered in New York, the US.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH710FSA
    PAGES: 53 TABLES: 24 FIGURES & CHARTS: 6
    $125.00
  3. U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic SWOT Analysis Review more info

    U.S. Physical Therapy, Inc. (USPh) operates outpatient physical therapy clinics that offer pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of injured workers and neurological-related injuries. In addition, the company operates a clinic which specialize in the outpatient, non-surgical treatment of osteo arthritis degenerative joint disease and other musculoskeletal conditions and provide services on behalf of third parties that provide physical therapy services. USPh operates through a network of 431 clinics in 43 states in the US.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH81644FSA
    PAGES: 33 TABLES: 21 FIGURES & CHARTS: 4
    $125.00
  4. Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review more info

    Bristol-Myers Squibb Company (BMS) is global biopharmaceutical company. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biopharmaceuticals and related healthcare products. The company focuses on the areas including cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/AIDS and rheumatoid arthritis. Its product line includes chemically-synthesized drugs and biological products. BMS has research and development facilities in the US, Belgium, England, France and Japan; and it also has manufacturing facilities in Puerto Rico, the US, France, Italy, Ireland, Japan, Mexico and China.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH10FSA
    PAGES: 60 TABLES: 28 FIGURES & CHARTS: 8
    $125.00
  5. Chelsea Therapeutics International Ltd. (CHTP) - Financial and Strategic SWOT Analysis Review more info

    Chelsea Therapeutics International Ltd. (Chelsea Therapeutics) is an early stage pharmaceutical company focuses on acquiring and developing products for the treatment of an array of human diseases. The company principally focuses on the development of drugs and technologies for the treatment of rheumatoid arthritis, autonomic nervous system conditions, psoriasis, inflammatory bowel disease, cancer and other disorders.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH66567FSA
    PAGES: 42 TABLES: 23 FIGURES & CHARTS: 6
    $125.00
  6. Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review more info

    Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization that offers integrated drug discovery, development and manufacturing services. AMRI’s core business consists of a fee-for-service contract services. Some of the key services the company offers include drug discovery and development, cGMP manufacturing at its various locations across the US and Asia, process scale-up development and aseptic filling services for projects in various stages of development and Analytical Services.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH7874FSA
    PAGES: 44 TABLES: 25 FIGURES & CHARTS: 6
    $125.00
  7. Brookdale Senior Living Inc. (BKD) - Financial and Strategic SWOT Analysis Review more info

    Brookdale Senior Living Inc. (Brookdale Senior Living) is an operator of senior living communities. The company's service portfolio comprises assisted living, independent living, alzheimer’s/ dementia care, skilled nursing centers, continuing care, retirement communities (CCRC) and life care by Brookdale. The company also offers management services to third parties. The company operates more than 647 senior living and retirement communities across 36 states in the US, providing services to more than 66,700 residents consisting of 221 owned, 329 leased and 97 managed communities. Brookdale Senior Living is headquartered in Tennessee, the US.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH27940FSA
    PAGES: 35 TABLES: 21 FIGURES & CHARTS: 4
    $125.00
  8. Grupo Casa Saba S.A. de C.V. - Financial and Strategic SWOT Analysis Review more info

    Grupo Casa Saba S.A.B. de C.V. (GCS) is a multi-channel and multi-product wholesale distributor. The company distributes pharmaceuticals, health and beauty, and consumer products. GCS organizes its business into four divisions, namely, Retail Pharmacy, Government Pharma, Pharma, Health, Beauty and Consumer Goods and Publications. It also offers general merchandise and publications such as books, magazines, albums and stickers. GCS’s distribution network comprises pharmacies owned by individuals, government pharmacies, regional and national supermarkets, nationwide agents, department stores, wholesalers and convenience stores. The company operates in Mexico, Chile, Peru and Brazil.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH29761FSA
    PAGES: 32 TABLES: 23 FIGURES & CHARTS: 6
    $125.00
  9. WellPoint, Inc. (WLP) - Financial and Strategic SWOT Analysis Review more info

    WellPoint, Inc. (WellPoint) is a health benefits company, which offers managed healthcare related products and services. The company offers a range of products including preferred provider organization (PPO) products, consumer driven health plans (CDHPs), traditional indemnity products, health maintenance organization (HMO) products, point-of-service (POS) products, administrative services, BlueCard, senior plans, individual plans, Medicaid plans, pharmacy products, life insurance, disability programs, behavioral health programs, long-term care insurance, vision services, and dental plans, among others.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH25012FSA
    PAGES: 48 TABLES: 22 FIGURES & CHARTS: 4
    $125.00
  10. Pozen, Inc. (POZN) - Financial and Strategic SWOT Analysis Review more info

    Pozen, Inc. (Pozen) is a progressive pharmaceutical company. It develops combination therapies for various therapeutic areas with particular focus on pain and pain related conditions. The company's products, in various stages of development are for the treatment of migraine, chronic pain, cardiovascular and gastrointestinal diseases. Pozen's commercial products include, Treximet, indicated for the treatment of migraine attacks, with or without aura, in adults; and Vimovo, to provide relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and to minimize the risk of developing NSAID-associated gastric ulcers.
    By: GlobalData
    , Published: Apr-2013
    , Product code: GDPH81713FSA
    PAGES: 47 TABLES: 24 FIGURES & CHARTS: 6
    $125.00

3610 Item(s)

Page 1 of 361